Human immunodeficiency virus type 2 reverse transcriptase activity in model systems that mimic steps in reverse...

Area of Science:

• Virology
• Molecular Biology
• Biochemistry

Background:

• Human immunodeficiency virus type 2 (HIV-2) infection poses a significant health challenge in West Africa and Asia.
• Research on HIV-2 reverse transcriptase (RT) is limited, yet it represents a crucial target for antiviral drug development.
• Comprehensive understanding of HIV-2 RT enzymatic functions is essential for creating effective high-throughput screening assays for potential inhibitors.

Purpose of the Study:

• To systematically evaluate the functional activities of HIV-2 reverse transcriptase (RT).
• To compare the enzymatic functions of HIV-2 RT with those of HIV-1 RT under various assay conditions.
• To elucidate the implications of observed differences for antiviral therapy strategies against HIV-2.

Main Methods:

• Conducted a systematic evaluation of HIV-2 RT function using assays modeling specific reverse transcription steps.
• Performed parallel studies comparing HIV-2 RT with HIV-1 RT.
• Assessed polymerase, RNase H activity, primer removal, and DNA synthesis initiation efficiency.

Main Results:

• HIV-2 RT and HIV-1 RT showed comparable polymerase and RNase H activities under standard conditions.
• HIV-2 RT exhibited significantly reduced activity compared to HIV-1 RT at lower enzyme concentrations.
• HIV-2 RT demonstrated impaired secondary RNase H cleavage and less efficient initiation of plus-strand DNA synthesis.

Conclusions:

• HIV-2 RT possesses distinct functional properties compared to HIV-1 RT, particularly concerning enzymatic activity at reduced concentrations and DNA synthesis initiation.
• Architectural differences in the palm subdomains may underlie the observed functional disparities between HIV-1 and HIV-2 RT.
• These findings provide critical insights for the rational design of antiviral therapies specifically targeting HIV-2 RT.